Project Details
| Short title | Phase Ib/II trial of atu027 in combination with cisplatin, 5-fu and Cetuximab in patients with head and neck cancer |
|---|---|
| Status | Finished |
| Effective start/end date | 1/04/14 → 31/12/17 |
Funding
- SILENCE THERAPEUTICS PLC
Phase Ib/II trial of atu027 in combination with cisplatin, 5-fu and Cetuximab in patients with head and neck cancer
- Mehanna, Hisham (Principal Investigator)